Literature DB >> 30737990

Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy.

Li Cui1, Gary Tse2,3, Zhiqiang Zhao4, George Bazoukis5, Konstantinos P Letsas5, Panagiotis Korantzopoulos6, Leonardo Roever7, Guangping Li4, Tong Liu4.   

Abstract

Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHCM) is an uncommon type of HCM. LV apical aneurysms are present in more than 20% MVOHCM cases and has been identified as an independent predictor of potentially lethal arrhythmic events, including non-sustained or sustained ventricular tachycardia (VT), and ventricular fibrillation (VF), as well as SCD. Although the pathogenesis of LVA remains unknown, but it has been suggested that apical aneurysm may be secondary to the increased after-load and high apical pressure arising from significant pressure gradient of the midventricular obstruction. The scarred rim of the aneurysm and the adjacent areas of LV myocardial fibrosis and consequent apical oxygen-demand mismatch may be responsible for the formation of apical aneurysm. Recent electrophysiologic studies have demonstrated that the aneurysmal rim forms the primary culprit arrhythmogenic substrate for generation of monomorphic ventricular tachycardia leading to SCD, but the clinical significance of the size of aneurysm in relation to SCD remains unsettled. We summarized the clinical features of the patients with MVOHCM and apical aneurysms. Appropriate therapeutic interventions include ICD implantation, and early surgical intervention for gradient relief may be undertaken to relief the MVO.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  apical aneurysm; hypertrophic cardiomyopathy

Mesh:

Year:  2019        PMID: 30737990      PMCID: PMC6931486          DOI: 10.1111/anec.12638

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  24 in total

1.  Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; John J Finley; J Martijn Bos; Thomas H Hauser; Warren J Manning; Tammy S Haas; John R Lesser; James E Udelson; Michael J Ackerman; Barry J Maron
Journal:  Circulation       Date:  2008-09-22       Impact factor: 29.690

Review 2.  Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

Authors:  Barry J Maron; Steve R Ommen; Christopher Semsarian; Paolo Spirito; Iacopo Olivotto; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

3.  Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy and Apical Aneurysm Mimicking Acute ST-Elevation Myocardial Infarction.

Authors:  Li Cui; Ya Suo; Yuntao Zhao; Guangping Li; Tong Liu
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-06-24       Impact factor: 1.468

4.  Transapical myectomy and surgical cryoablation for refractory ventricular tachycardia due to hypertrophic cardiomyopathy with apical aneurysm.

Authors:  Yusuke Shimahara; Junjiro Kobayashi; Tomoyuki Fujita; Shunsuke Sato
Journal:  Eur J Cardiothorac Surg       Date:  2014-10-01       Impact factor: 4.191

5.  Left ventricular aneurysms in hypertrophic cardiomyopathy with midventricular obstruction: A systematic review of literature.

Authors:  Moustafa O Elsheshtawy; Ahmed N Mahmoud; Mahmoud Abdelghany; Ida H Suen; Adnan Sadiq; Jacob Shani
Journal:  Pacing Clin Electrophysiol       Date:  2018-06-20       Impact factor: 1.976

6.  Hypertrophic cardiomyopathy with apical aneurysm: left ventricular reconstruction and cryoablation for ventricular tachycardia.

Authors:  Hajime Osawa; Toshihiro Fujimatsu; Fumie Takai; Hiroyuki Suzuki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-05-06

7.  Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.

Authors:  Ethan J Rowin; Barry J Maron; Tammy S Haas; Ross F Garberich; Weijia Wang; Mark S Link; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2017-02-21       Impact factor: 24.094

8.  Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.

Authors:  Chi Cai; Fu-jian Duan; Yin-jian Yang; Xi-ying Guo; Yan-ling Liu; Yu-qing Liu; Li-rong Yan; Zhi-min Xu; Shi-hua Zhao; Wei Hua; Yi-shi Li; Chao-mei Fan
Journal:  Can J Cardiol       Date:  2013-10-09       Impact factor: 5.223

9.  Mid-ventricular Hypertrophic Obstructive Cardiomyopathy with Apical Aneurysm Complicated with Syncope by Sustained Monomorphic Ventricular Tachycardia.

Authors:  Andrés Ricardo Pérez-Riera; Raimundo Barbosa-Barros; Augusto Armando de Lucca; Mujimbi Jose Viana; Luiz Carlos de Abreu
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-07-16       Impact factor: 1.468

10.  Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis.

Authors:  Qun Liu; Diandian Li; Alan E Berger; Roger A Johns; Li Gao
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

View more
  1 in total

1.  Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Clin Cardiol       Date:  2021-02-24       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.